The Current Ratio as of December 2024 (TTM) for Aldeyra Therapeutics, Inc. (ALDX) is 6.80

According to Aldeyra Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.80. This represents a change of 14.28% compared to the average of 5.95 of the last 4 quarters.

Aldeyra Therapeutics, Inc. (ALDX) Historical Current Ratio (quarterly & annually)

How has ALDX Current Ratio performed in the past?

The mean historical Current Ratio of Aldeyra Therapeutics, Inc. over the last ten years is 10.58. The current 6.80 Current Ratio has changed 6.33% with respect to the historical average. Over the past ten years (40 quarters), ALDX's Current Ratio was at its highest in in the June 2021 quarter at 34.59. The Current Ratio was at its lowest in in the June 2024 quarter at 4.41.

Aldeyra Therapeutics, Inc. (ALDX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aldeyra Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aldeyra Therapeutics, Inc. (ALDX) Average Current Ratio

How has ALDX Current Ratio performed in the past?

The current Current Ratio of Aldeyra Therapeutics, Inc. (ALDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aldeyra Therapeutics, Inc. (ALDX) Current Ratio vs. Peers

How is ALDX’s Current Ratio compared to its peers?

Aldeyra Therapeutics, Inc.’s Current Ratio is greater than Tarsus Pharmaceuticals, Inc. (5.42), less than LianBio (10.06), greater than Travere Therapeutics, Inc. (1.71), greater than Eton Pharmaceuticals, Inc. (1.51), less than Viridian Therapeutics, Inc. (18.55), less than Terns Pharmaceuticals, Inc. (32.99), less than Structure Therapeutics Inc. (27.63), greater than Blueprint Medicines Corporation (3.32), less than 89bio, Inc. (11.66), greater than X4 Pharmaceuticals, Inc. (4.89), less than Inozyme Pharma, Inc. (7.68), less than Day One Biopharmaceuticals, Inc. (14.62), greater than HOOKIPA Pharma Inc. (3.26), greater than Phathom Pharmaceuticals, Inc. (5.73), greater than Lyra Therapeutics, Inc. (3.64), less than Cullinan Oncology, Inc. (24.46), greater than BioLineRx Ltd. (1.52), greater than Ardelyx, Inc. (4.03), less than Lexicon Pharmaceuticals, Inc. (7.45), greater than Seres Therapeutics, Inc. (1.12), greater than ImmunityBio, Inc. (2.68),

Build a custom stock screener for Aldeyra Therapeutics, Inc. (ALDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aldeyra Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aldeyra Therapeutics, Inc. (ALDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aldeyra Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.